Lichen planus is an uncommon inflammatory mucocutaneous disorder affecting the skin and its appendages, as well as oral and genital mucosa. Involvement ofthe esophageal mucosa is rare and causes significant morbidity, with dysphagia and risk of long-term complications, such as esophageal strictures and stenosis. Esophageal lichen planus is an underreported condition in the spectrum of lichenoid tissue reactions, presenting the risk of systemic manifestations. We describe a patient with severe, long-standing esophageal lichen planus, which had led to marked weight-loss, malnutrition syndrome and chronic respiratory distress due to recurrent aspiration pneumonia. Diagnosis was confirmed by the presence of concomitant muco-cutaneous lesions and characteristic endoscopic and histological findings. Systemic therapy with cyclosporine A and micronutrient supplementation led to rapid clinical improvement. Early diagnosis of esophageal lichen planus as well as effective systemic immunosuppressive treatment is crucial in order to prevent short-and long-term complications.
Lichen planus (LP) isan autoimmune inflammatory disease which involves the skin and its appendages and the mucous membranes, most frequently the oral and genital mucosa. The etiopathogenesis of LP is probably related to an autoimmune cytotoxic T-cell mediated attack to the epithelial basal cell layer (I).
The clinical presentation and course vary depending on the area involved and the severity of the lesions, as the erosive forms may cause fibrosis and scarring. We report a case of esophageal lichen planus, a rare clinical variant of LP, which can cause systemic complications.
MATERIALS AND METHODS
A 62-year-old woman was admitted to our inpatient clinic due to progressive dysphagia, marked weight loss (20 kg) and fever. She had a 12-month long history of dysphagia, which progressed from solid to liquid foods. During the last three months she also developed skin lesions, with eruptive, symmetrically distributed, erythemato-squamous pruritic plaques on the scalp, limbs and nipples, and erosive cheilitis (Fig, I , a-b). She was admitted to our inpatient clinic due to fever, severe asthenia and respiratory distress, in order to receive supportive care and diagnostic work-up. She was otherwise affected by chronic active HeV-related liver disease (genotype 1b), which was refractory to uinterferon and ribavirin therapy, and had an 8-year history of resected colon cancer. On clinical inspection she also presented other muco-cutaneous lesions, such as small patches of alopecia with follicular hyperkeratosis, atrophy of the oral mucosa without leukoplakia, hyperkeratosis of the nails and xerophthalmia with conjunctival hyperemia and night-blindness. Histological examina.li...on_~f lesional skin documented an interface dermatitis pattern as shown in Fig. 2a . On endoscopy the esophageal mucosa appeared inflamed, friable and prone to bleeding with linear ulcerations and white pseudomembranes involving the mid and distal thirds of the esophagus. Gastric and duodenal mucosa were both spared from inflammation and ulcerations. Biopsy of the inflamed esophageal mucosa revealed lymphocytic exocytosis and presence of numerous Civatte bodies, consistent with a diagnosis of esophageal lichen planus (ELP) (Fig. 2b ) . Direct immunofluorescence was negative for both skin and esophageal mucosa. Extensive research of an occult neoplasia was also undertaken. Colonoscopy revealed a single granular-type lateral spreading tumour, a superficial spreading neoplasm, involving the sigma, which was promptly subjected to endoscopic mucosal resection . Thorax CT scans documented diffuse bronchial wall thickening and bronchiectasis in the middle and lower lobes ofboth lungs with air trapping. Pulmonary aspiration was confirmed by bronchoscopy and bacterial cultures from bronchoalveolar lavage fluids yielded positive results for S.aureus colonization. Laboratory examinations were negative for autoimmunity and inflammatory markers were in the normal range. Hypoproteinemia (5 gr/dl), hypoalbuminemia (3 gr/dl), and low serum levels of Vitamin B 12 (1599 pg/ml) and folates resulted from malnutrition secondary to severe dysphagia, whereas zinc serum levels were in the normal range.
RESULTS
Due to severe mucocutaneous LP lesions and systemic involvement, treatment with cyclosporine A at 3 mg/kg BW/daily dose (125 mg/daily) was started, in combination with proton-pump inhibitors, sucralfate, systemic antibiotics (Ievofloxacin) and supportive care (oxygen therapy, parenteral nutrition and vitamin supplementation). Cyclosporine serum levels were checked during the first week of treatment, in order to ensure therapeutic levels. After 8 weeks of treatment there was clinical remission of skin lesions and marked improvement of dysphagia, dyspnea and reepithelization ofeosophageal mucosal lesions on endoscopy. The patient experienced also modest weight-gain (6 kg.) and an improvement of general condition. Cyclosporine A treatment was continued for a total of24 weeks and then interrupted. During follow-up (12 months) the patient did not present relapse of skin lesions, nor esophageal strictures or any sign of malignant transformation of the esophageal mucosa on endoscopy. The night-blindness recovered 2 months after vitamin A supplementation.
DISCUSSION
Esophageal Lichen planus (ELP) is a rare mucosal manifestation of LP and typically affects middle-aged women with symptoms of dysphagia, odynophagia and weight-loss, but it can run asymptomatic in many patients affected by LP (2) . ELP is usually associated with other preexistent or concomitant lichen planus (LP) lesions, in more than half of the cases with oral and vulvar lesions (3). In our case, ELP was associated with cutaneous lesions in the setting of chronic HCY liver disease and presented a severe course requiring hospitalization. Persistent dysphagia had led to marked weight loss, malnutrition and a secondary respiratory distress due to recurrent episodes of aspiration pneumonia. Differential diagnosis of ELP includes pemphigus vulgaris , paraneoplastic pemphigus, bullous pemphigoid, lichenoid graft versus host disease and lichenoid drug eruptions. In our case major points for diagnosis were the severe, persistent 
. a) Lesional skin biopsy showing a chronic stage-interface dermatitis pattern -hyperkeratosis, vacuolization and consumption of basal cell layer of the epidermis and a band-like lymphocytic infiltrate in the superficial dermis. b) Histology ofesophageal Lichen planus showing a dense lymphocytic inflammatory infiltrate of the mucosal epithelium and lamina propria with presence ofnumerous Civatte bodies (necrotic keratinocytes).
dysphagia and typical lichenoid cutaneous lesions developing in a middle-aged woman, affected by chronic HCV infection. Furthermore, in our case the clinical picture ofELP was complicated by signs and symptoms of secondary malnutrition and Vitamin A and 89 deficiencies, which contributed respectively to xeropthalmialnight-blindness and aggravation of erosive cheilitis. Final diagnosis of ELP was then confirmed by distinctive endoscopic and histological findings. Endoscopy indeed represents the goldstandard for the diagnosis of ELP, and involvement of the proximal and mid thirds of the esophagus is characteristic, showing variable , subtle findings like friability and bleeding of inflamed mucosa , lacy white patches and pseudomembranes, erosions, ulcerations and strictures. Endoscopy should be performed in patients affected by oral, genital or cutaneous LP reporting dysphagia, odynophagia and! or weight loss, especially in the absence of a history of gastroesophageal reflux. Histopathology of lesional esophageal mucosa is an important clue for differential diagnosis with other diseases affecting the esophagus (gastroesophageal reflux disease, eosinophilic esophagitis, fungal infections, Crohn's disease) , but it can also be inconclusive in some cases due to insufficient tissue sampling. In ELP, as in other severe-generalized clinical variants of LP, systemic treatment is warranted in order to prevent long-term fibrotic complications, such as esophageal strictures and stenosis . Systemic treatment options for ELP include both conventional (high-dose systemic corticosteroids, azathioprine and systemic retinoids) and biological agents, such as rituximab, but, as in severe LP, there are no comprehensive treatment guidelines (4, 5) . Calcineurin inhibitors (cyclosporine A, tacrolimus) are considered secondline agents for the treatment of LP and should be used as systemic therapy, as efficacy of topical administration has been recently questioned in oral LP (6) . In our case systemic cyclosporine A (CsA) was preferred due to its rapid onset of action and high efficacy in severe cutaneous LP. CsA serum concentration is infrequently measured in the setting of autoimmune disease, but in our case monitoring was necessary due to a concomitant malnutrition syndrome, a body-weight dependent dosing scheme and risk of drug interactions. Furthermore, CsA represents a safe treatment option for autoimmune disease and concomitant chronic HCV infection, because it inhibits the viral calcineurin of HCV (7) . CsA was previously used only in one case of ELP resistant to systemic corticosteroids (8) . Other treatment modalities include endoscopic intralesional injection of corticosteroids and endoscopic dilation of esophageal strictures, albeit carrying the risk of triggering an inflammatory flare via the Koebner phenomenon (9) . Adjunctive treatment of acid reflux with proton pump inhibitors is also useful in order to prevent further inflammation of the esophageal mucosa. Mucosal lichenoid lesions are commonly considered at low-to intermediate (0.6% to 5.32%) risk for the development of squamous cell carcinoma (SCC) and its precursors. To date only 4 cases of long-standing, erosive ELP have been complicated by malignant transformation and progression to SCC (3). In our case endoscopy and histology of the esophageal mucosa ruled out SCC precursor lesions. Screening for an occult neoplasia led to the diagnosis of a superficial-spreading tumour of the sigma in a patient with a history of colon cancer. This finding was considered unrelated to ELP. Long-term followup of ELP patients during immunosuppressive treatment is crucial in order to detect progression to esophageal SCC and the occurrence of secondary malignancies, especially in our case, a patient with chronic HCY infection and history of colon cancer receiving treatment with calcineurin-inhibitors. In conclusion, we present a case of esophageal lichen planus presenting with severe systemic involvement, respiratory distress and malnutrition syndrome. Mucocutaneous lichen planus with esophageal involvement can sometimes run an aggressive course, requiring hospitalization and extensive diagnostic work-up as well as effective systemic treatment, in order to prevent long-term complications.
